Does TUCATINIB Cause Hyperkeratosis? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hyperkeratosis have been filed in association with TUCATINIB (TUKYSA). This represents 0.1% of all adverse event reports for TUCATINIB.
7
Reports of Hyperkeratosis with TUCATINIB
0.1%
of all TUCATINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Hyperkeratosis From TUCATINIB?
Of the 7 reports, 1 (14.3%) required hospitalization.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCATINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TUCATINIB Cause?
Diarrhoea (1,587)
Nausea (862)
Fatigue (843)
Vomiting (483)
Death (400)
Off label use (392)
Malignant neoplasm progression (361)
Palmar-plantar erythrodysaesthesia syndrome (355)
Product dose omission issue (332)
Asthenia (322)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which TUCATINIB Alternatives Have Lower Hyperkeratosis Risk?
TUCATINIB vs TUCIDINOSTAT
TUCATINIB vs TYKERB
TUCATINIB vs TYLENOL
TUCATINIB vs TYROTHRICIN
TUCATINIB vs TYSABRI